General Information
BounceWatch is an independent company data service, not affiliated with Organo-ID. To contact Organo-ID, visit organo-id.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Organo-ID compare?
A PDF of Organo-ID and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Organo-ID soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Organo-ID on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Turkey Market
Biotechnology
About Organo-ID
Business keywords: Preclinical Disease Models, In vitro disease models, Organoid technologies, Human cancer, Liver pathologies, Metabolic liver disease, Rare diseases, Cancer treatment response testing, Personalized oncology, 3D cell culture, iPSC, Stem cell expertise
Services & Products
Target Customers
Funding Rounds & Investors (2)
View AllOrgano-ID Alternatives & Competitors
View All AlternativesOur Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...
The Newcells ophthalmology business was acquired by Axol Bioscience
Developing new treatments for rare metabolic disorders
FAQ About Organo-ID
Source: BounceWatch company record for Organo-ID, https://bouncewatch.com/company/organo-id, updated 25 September 2026. When citing, please name BounceWatch and link this page.